1. Home
  2. MBIN vs XNCR Comparison

MBIN vs XNCR Comparison

Compare MBIN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merchants Bancorp

MBIN

Merchants Bancorp

N/A

Current Price

$49.51

Market Cap

2.3B

Sector

Finance

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$33.57

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MBIN
XNCR
Founded
1990
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.0B
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
MBIN
XNCR
Price
$49.51
$33.57
Analyst Decision
Hold
Buy
Analyst Count
3
14
Target Price
★ $67.00
$43.83
AVG Volume (30 Days)
115.6K
★ 1.5M
Earning Date
10-28-2026
11-04-2026
Dividend Yield
★ 0.88%
N/A
EPS Growth
N/A
★ 65.36
EPS
★ 4.79
N/A
Revenue
N/A
★ $125,576,000.00
Revenue This Year
$10.52
$58.19
Revenue Next Year
$3.15
N/A
P/E Ratio
$10.44
★ N/A
Revenue Growth
N/A
★ 13.65
52 Week Low
$30.95
$10.38
52 Week High
$56.87
$40.60

Technical Indicators

Market Signals
Indicator
MBIN
XNCR
Relative Strength Index (RSI) 39.73 54.03
Support Level $47.81 $22.80
Resistance Level $51.01 $33.60
Average True Range (ATR) 1.40 2.08
MACD -0.36 -0.54
Stochastic Oscillator 3.97 35.21

Price Performance

Historical Comparison
MBIN
XNCR

About MBIN Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: